Clinical evaluation of autonomous, unsupervised planning integrated in MR-guided radiotherapy for prostate cancer.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 35134447.
- Also identified by DOI 10.1016/j.radonc.2022.01.036.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This retrospective study aimed at clinical evaluation of autonomous radiotherapy planning for ten prostate cancer cases, including organ-at-risk/target contouring and treatment planning. Five experts scored the clinical acceptability of each step using a 4-level Likert-scale resulting in 78%, 66% and 90% acceptance. For 6/10 patients the entire workflow was considered acceptable.
Medical subject headings
- Prostatic Neoplasms
- Radiotherapy, Image-Guided